The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
A recent Morbidity and Mortality Weekly Report (MMWR) highlights the risks associated with use of over-the-counter (OTC) products containing undeclared prescription ingredients as well as the importance of collaboration between various health departments and systems to ensure a prompt response to an outbreak.
There is a lack of evidence supporting the use of dietary supplements for the prevention or treatment of COVID-19, despite what recent news or social media platforms have asserted.
Gabapentin may be a beneficial therapeutic option for managing vasomotor symptoms in postmenopausal women.
Previous research has suggested that treatment with metformin may potentially lower the risk of dementia, however whether the timing of treatment impacts this result remains unclear.
After obtaining a more detailed history, it was discovered that the patient had been reusing insulin needles and was not rotating sites for insulin injection.
In order to provide national guidance addressing issues surrounding pain management practices, an expert panel was convened to provide a framework for pain practitioners and institutions.
According to the findings of this post-hoc analysis, there appears to be a consistent clinical benefit with dapagliflozin in HFrEF patients regardless of background HF therapy.
Rotavirus vaccination does not appear to increase or decrease the risk of developing type 1 diabetes, according to the findings of a recently published retrospective cohort study.